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CASE REPORT
With the frequent utilization of laboratory exam-
inations, most cases of primary hyperparathyroi-
dism are now found incidentally with no apparent
clinical symptoms. However, rare cases, especially
observed in the parathyroid carcinomas rather
than adenomas, may present with severe hyper-
calcemic crisis and markedly elevated parathy-
roid hormone (PTH) levels.1 In addition, anemia
has not been appreciated as a common compli-
cation of primary hyperparathyroidism;2 myelofib-
rosis in primary hyperparathyroidism is also rarely
seen. Here, we report a case of benign parathyroid
adenoma, presenting with unusual manifestations
of parathyroid storm, as parathyroid carcinoma,
and accompanied by anemia and myelofibrosis.
Hematologic parameters improved after parathy-
roidectomy. The infrequent association of anemia,
myelofibrosis, and primary hyperparathyroidism
are discussed and reviewed.
Case Report
A 58-year-old woman, who had experienced fati-
gue, general malaise, polydipsia, and aggravated
sacrum pain for 2 weeks, was admitted to our
hospital. A review of her medical history revealed
that she was relatively well, although she had 
hypertension for 7–8 years. There was no family
history of nephrolithiasis or osteoporosis. She
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denied taking thiazide, diuretics, lithium, herb sup-
plements, or vitamins. On physical examination,
her blood pressure was 103/53 mmHg, pulse rate
was 80/minute, and temperature was 36.6°C. Pal-
pation revealed a mass lesion, measuring about
2 cm, over the right lower neck. No neck lymph-
adenopathy, trachea deviation, or splenomegaly
was noted at the same time. On admission, lab-
oratory evaluation (Table) showed the following
values: hemoglobin, 7.4 g/dL (range, 12.0–16.0);
mean corpuscular volume (MCV), 90.1μm3 (range,
80–100); white blood cell (WBC) count, 6410/
mm3; platelet, 164×103/mm3 (range, 150×103–
400 × 103); albumin, 4.6 g/L (range, 3.5–5.0);
high alkaline phosphatase level, 297 U/L (range,
30–120); creatinine, 1.6 mg/dL (range, 0.5–1.5);
blood urea nitrogen, 19 mg/dL (range, 5–25); se-
rum phosphorus, 2.6 mg/dL (range, 2.5–4.5); and
serum calcium up to 16.2mg/dL (range, 9–11).
Hormone survey showed extremely high intact
PTH level up to 1048 pg/mL (range, 12–72). Neck
ultrasound tomography revealed a hypoechoic,
regularly contoured nodular lesion, measuring
1.39 × 1.57 cm, in the lower portion of the right
thyroid lobe. Technetium-99 m sestamibi scanning
showed an area of significantly increased uptake
in the lower portion of the right thyroid bed both
on the early and delayed images. Abdominal ultra-
sound showed no renal stone or splenomegaly.
Bone marrow biopsy showed moderate erythroid
hypoplasia with patchy moderate reticulin fibrosis
(Figure 1). A diagnosis of primary hyperparathy-
roidism with anemia and secondary myelofibrosis
was thus established. She received aggressive intra-
venous fluid infusion with furosemide and bisphos-
phonate for the hypercalcemic crisis. Symptoms
of bone pain regressed under analgesics and bisphos-
phonate. Four-gland exploration surgery was per-
formed and the right inferior parathyroid gland,
measuring 3.0 × 2.0 × 0.7 cm, was excised. Patho-
logy disclosed a benign chief cell parathyroid
adenoma (Figure 2). Intact PTH decreased to
34.3 pg/mL soon after and calcium decreased to
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Figure 1. The picture shows patchy reticulin myelofibrosis
containing an increased number of fibroblasts. Osteoclastic
and osteoblastic activity is also apparent along the bony
trabecula (hematoxylin & eosin, 200×).
Table. Pre- and postparathyroidectomy laboratory data
Normal range Value on admission
Postoperative
4 mo 1 yr
Hemoglobin, g/dL 12.0–16.0 7.4 10.6 11.8
Hematocrit, % 38–47 30.1 31.7 34.8
MCV, μm3 80–100 90.1 86.4 82.3
Platelets 150 × 103–400 × 103 164,000 204,000 294,000
Serum calcium, mg/dL 9–11 16.2 9.5 9.9
Intact PTH, pg/mL 12–72 1048 56.5 29.5
Serum phosphorus, mg/dL 2.5–4.5 2.6 5
Serum alkaline phosphatase, IU/L 30–120 297 75
24-hr urinary calcium, mg/d 100–240 305.5 69.3
Serum creatinine, mg/dL 0.5–1.5 1.6 1.7 1.5
24-hr urine Ccr 42.23 54.31
MCV = mean corpuscular volume; PTH = parathyroid hormone.
9.9 mg/dL 2 days after parathyroidectomy. The
postoperative course was uneventful. One year
later, follow-up series showed hemoglobin
11.8 g/dL and serum calcium 9.9 mg/dL (Table).
Discussion
Primary hyperparathyroidism usually follows a
chronic and asymptomatic course. However, rarely,
it may present with acute severe hypercalcemia
and life-threatening disturbances, such as meta-
bolic encephalopathy, cardiac arrhythmia, and
renal failure, the so-called severe primary hyper-
parathyroidism.1,3 In these cases, blood calcium
levels may be as high as 14–25 mg/dL,3,4 and cir-
culating PTH levels may be up to 10 times higher
than the upper normal values.5,6 It has been re-
ported that severe hyperparathyroidism may
occur in 1.6–4% of all primary hyperparathyroid 
patients.4 The differential diagnosis between
adenoma and carcinoma is difficult before para-
thyroidectomy, although some reports have pro-
posed that parathyroid carcinoma tends to be
larger, often exceeding 10 g, and is palpable as a
neck mass with more aggressive presentation of
hyperparathyroid storm.7,8 In our patient, the
parathyroid lesion was large enough to be palpa-
ble and manifested by acute hyperparathyroidism.
But the final pathology disclosed parathyroid ade-
noma instead of parathyroid carcinoma. It has
been suggested that parathyroid adenomas may
suddenly secrete large quantities of PTH into the
blood stream, resulting in dramatically increased
blood calcium levels and catastrophic clinical
consequences, which may mimic parathyroid
carcinomas.3,4,9
On the other hand, anemia has been reported
as another associated complication of primary
hyperparathyroidism.2,10 The incidences of ane-
mia in primary hyperparathyroidism ranged 
between 2% and 38%, and most were nor-
mochromic and normocytic anemia with no ab-
normality in WBC and platelet counts.2,10 Several
possible mechanisms of anemia in primary hyper-
parathyroidism have been proposed. First, patients
with hyperparathyroidism may more easily suffer
from peptic ulcer or renal insufficiency, which in
turn can result in anemia.2,10 In our patient, mild
impaired renal function appeared to work upon
the anemia partly. Second, some experiments
have demonstrated that intact PTH has an in-
hibitory effect on the growth of erythroid progeni-
tor cells, mainly at the stage of burst forming
units-erythyroid, in a dose-dependent manner and
erythropoietin synthesis.11,12 However, another
study reported that pure intact PTH could not
significantly inhibit hematopoietic colony growth
as crude parathyroid gland extracts could. And 
it was postulated that some materials inside the
extracts, rather than intact PTH, may have an im-
pact on erythropoiesis.13 Clinically, it has been 
reported that patients with primary hyperpara-
thyroidism accompanied by anemia have more
elevated PTH levels, and after parathyroidec-
tomy, this anemia may regress or even re-
solve.10,11,14 The hemoglobin level of our patient
improved after parathyroidectomy without any
other intervention. This finding implies that high
preoperative PTH levels may at least contribute
to the development of anemia.
It has been reported that myelofibrosis can
occur in patients with excessive PTH and the
severity of myelofibrosis correlates with serum PTH
level.15,16 In addition, some studies have pointed
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Figure 2. Adenoma composed of chief cell was character-
ized by clear or abundant granular cytoplasm and centrally
located nuclei. Several clusters of atypical cells with bizarre
nuclei were also seen. Neither mitotic figures nor capsular 
invasion were found. Highly vascularized background was
noted (hematoxylin & eosin, 200×).
out that myelofibrosis may regress after parathy-
roidectomy.11,15 It was proposed that an excessive
PTH level mediates the selective cytokine accumu-
lation or paracrine factors in bone marrow, such as
IL-1α, IL-6, tumor necrosis factor-α, transforming
growth factor-β, and platelet-derived growth fac-
tor A, which in turn cause tissue fibrosis.17,18 PTH
has a potent stimulatory effect on fibroblast pro-
liferation and PTH receptors have been described
on fibroblasts before.19 Of note is a recent study
in animals, which demonstrated that intermittent
PTH infusion can promote marrow fibroblasts to
differentiate into osteoblasts. It was stated that os-
teoblasts are specialized fibroblasts, and morpho-
logically, preosteoblasts may sometimes mimic the
fibroblasts. Therefore, it seems that preosteoblasts
may partly contribute to the myelofibrosis change
seen in hyperparathyroidism. And the differen-
tials between preosteoblasts and fibroblasts could
be recognized by their location on bone surfaces,
expression of osteoblast marker proteins, and
ability to differentiate into obsteoblasts.18
Hyperparathyroidism-related myelofibrosis, as
in our patient, usually lacks a general morphologic
sign of myelofibrosis, such as hepatosplenomegaly
or leukoerythroblastosis.20 Kumbasar et al21 re-
ported another rare case with myelofibrosis sec-
ondary to hyperparathyroidism. On the basis of
the finding that both anemia and myelofibrosis
improved after parathyroidectomy, it was specu-
lated that myelofibrosis contributed at least partly
to anemia in hyperparathyroidism.
In conclusion, we report a case of benign para-
thyroid adenoma, presenting with hypercalcemia
crisis, which may mimic parathyroid carcinoma.
In addition, we must also be aware of anemia
and myelofibrosis as a possible complication in
primary hyperparathyroidism.
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